Twist Bioscience/TWST

$29.24

-4.69%
-
1D1W1MYTD1YMAX

About Twist Bioscience

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Ticker

TWST

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Emily Leproust

Employees

919

Headquarters

South san francisco, United States

Twist Bioscience Metrics

BasicAdvanced
$1.77B
Market cap
-
P/E ratio
-$3.60
EPS
1.64
Beta
-
Dividend rate
$1.77B
1.64037
$43.21
$11.46
877.55K
5.983
5.509
-25.06%
-30.8%
-27.56%
6.761
3.004
3.933
21.58%
6.53%
39.6%

What the Analysts think about Twist Bioscience

Analyst Ratings

Majority rating from 10 analysts.
Buy

Price Targets

Average projection from 8 analysts.
37.24% upside
High $48.00
Low $25.00
$29.24
Current price
$40.13
Average price target

Twist Bioscience Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-60.22% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$71.4M
6.73%
Net income
$-43M
-6.93%
Profit margin
-60.22%
-12.79%

Twist Bioscience Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.52%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.04
-$1.01
-$0.81
-$0.75
-
Expected
-$1.12
-$1.14
-$0.92
-$0.78
-$0.82
Surprise
-7.21%
-11.24%
-12.06%
-3.52%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Twist Bioscience stock?

Twist Bioscience (TWST) has a market cap of $1.77B as of April 16, 2024.

What is the P/E ratio for Twist Bioscience stock?

The price to earnings (P/E) ratio for Twist Bioscience (TWST) stock is 0 as of April 16, 2024.

Does Twist Bioscience stock pay dividends?

No, Twist Bioscience (TWST) stock does not pay dividends to its shareholders as of April 16, 2024.

When is the next Twist Bioscience dividend payment date?

Twist Bioscience (TWST) stock does not pay dividends to its shareholders.

What is the beta indicator for Twist Bioscience?

Twist Bioscience (TWST) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Twist Bioscience stock price target?

The target price for Twist Bioscience (TWST) stock is $40.13, which is 37.24% above the current price of $29.24. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Twist Bioscience stock

Buy or sell Twist Bioscience stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing